-
15427-1An orally available, selective inhibitor of both free and prothrombinase-bound factor Xa (Ki = 0.8 nM) effective anticoagulant in both preclinical and clinical models of venous and arterial thrombosis.
-
15427-10An orally available, selective inhibitor of both free and prothrombinase-bound factor Xa (Ki = 0.8 nM) effective anticoagulant in both preclinical and clinical models of venous and arterial thrombosis.
-
15427-5An orally available, selective inhibitor of both free and prothrombinase-bound factor Xa (Ki = 0.8 nM) effective anticoagulant in both preclinical and clinical models of venous and arterial thrombosis.
-
15427-50An orally available, selective inhibitor of both free and prothrombinase-bound factor Xa (Ki = 0.8 nM) effective anticoagulant in both preclinical and clinical models of venous and arterial thrombosis.
-
11976-1An inhibitor of NADPH-oxidase complex assembly that at 300 &muM is effective in preventing the production of superoxide in human white blood cells or neutrophilic granulocytes widely used as an inhibitor of NADPH oxidase activity in the treatment
-
11976-10An inhibitor of NADPH-oxidase complex assembly that at 300 &muM is effective in preventing the production of superoxide in human white blood cells or neutrophilic granulocytes widely used as an inhibitor of NADPH oxidase activity in the treatment
-
11976-5An inhibitor of NADPH-oxidase complex assembly that at 300 &muM is effective in preventing the production of superoxide in human white blood cells or neutrophilic granulocytes widely used as an inhibitor of NADPH oxidase activity in the treatment
-
19435-100An apoptosis inducer that inhibits the mitochondrial F1FO ATPase (Ki = 4-5 µM) selectively kills transformed glial cells without significantly affecting untransformed cells.
-
19435-500An apoptosis inducer that inhibits the mitochondrial F1FO ATPase (Ki = 4-5 µM) selectively kills transformed glial cells without significantly affecting untransformed cells.
-
10004176-10Promotes the cytochrome c-dependent oligomerization of Apaf-1 into the mature apoptosome, thus increasing procaspase-9 processing and subsequent caspase-3 activation induces apoptosis in leukemia cells (IC50 = 4-9 &muM)
-
10004176-25Promotes the cytochrome c-dependent oligomerization of Apaf-1 into the mature apoptosome, thus increasing procaspase-9 processing and subsequent caspase-3 activation induces apoptosis in leukemia cells (IC50 = 4-9 &muM)
-
10004176-5Promotes the cytochrome c-dependent oligomerization of Apaf-1 into the mature apoptosome, thus increasing procaspase-9 processing and subsequent caspase-3 activation induces apoptosis in leukemia cells (IC50 = 4-9 &muM)